Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases

Cardiovasc Res. 2014 Apr 1;102(1):17-23. doi: 10.1093/cvr/cvu035. Epub 2014 Feb 11.

Abstract

Cyclophilin A (CyPA) is an abundantly expressed intracellular protein. It exerts a variety of functions due to its peptidyl-prolyl cis-trans isomerase (PPIase) activity. When released into the extracellular space, CyPA binds to its extracellular receptor CD147 (EMMPRIN) and thereby initiates a cascade of inflammatory processes. Recent data indicate that both extra- and intracellular CyPA significantly contribute to cardiovascular inflammation, myocardial ischaemia and reperfusion injury, and myocardial remodelling processes. Thus, CyPA appears to represent a novel target to treat vascular and myocardial inflammation.

Keywords: Cyclophilin A; EMMPRIN; Inflammation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Basigin / immunology
  • Basigin / metabolism*
  • Blood Platelets / metabolism
  • Cardiovascular Diseases / immunology
  • Cardiovascular Diseases / metabolism*
  • Cyclophilin A / immunology
  • Cyclophilin A / metabolism*
  • Humans
  • Inflammation / immunology
  • Inflammation / metabolism
  • Myocardium / metabolism

Substances

  • Basigin
  • Cyclophilin A